22147-Gall Bladder Cancer-NA-1598

Gall Bladder Cancer

A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen (CTX-009-002)

  • Details

ClinicalTrials.gov ID: NCT05506943
Diagnosis Type: NA
USOR Number:

  • Address

5125 Texoma Medical Center Dr.
Denison, TX 75020
P: 903-868-4700

Search by practice name, trial titles, indicators and specific disease types.